Jupiter Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Jupiter Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	+736	New	+$173K	﹤0.01%	508
2024 Q2	–	Sell	-5,755	Closed	-$421K	–	435
2024 Q1	$421K	Hold	5,755	–	–	﹤0.01%	396
2023 Q4	$411K	Hold	5,755	–	–	﹤0.01%	419
2023 Q3	$345K	Hold	5,755	–	–	﹤0.01%	449
2023 Q2	$414K	Hold	5,755	–	–	﹤0.01%	465
2023 Q1	$422K	Hold	5,755	–	–	0.01%	380
2022 Q4	$384K	Sell	5,755 -3,470	-38%	-$226K	0.01%	419
2022 Q3	$496K	Hold	9,225	–	–	0.01%	436
2022 Q2	$512K	Sell	9,225 -16,285	-64%	-$924K	0.01%	487
2022 Q1	$1.79M	Sell	25,510 -467	-2%	-$33.9K	0.02%	362
2021 Q4	$2.53M	Sell	25,977 -2,569	-9%	-$237K	0.03%	326
2021 Q3	$2.48M	Hold	28,546	–	–	0.03%	325
2021 Q2	$2.33M	Hold	28,546	–	–	0.02%	377
2021 Q1	$2.71M	Sell	28,546 -18,749	-40%	-$1.77M	0.03%	380
2020 Q4	$2.93M	Buy	+47,295	New	+$2.7M	0.03%	384

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Asset Management's LGND Position: Q2 2026 in Review

Jupiter Asset Management opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 736 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #508 among its holdings. This is a return to the name: Jupiter Asset Management previously reported a position in LGND as recently as Q1 2024.

Jupiter Asset Management first reported a position in LGND in Q4 2020 and has held it in 15 quarters since. The position peaked at $2.93M in Q4 2020. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Jupiter Asset Management held 736 shares of Ligand Pharmaceuticals worth $233K as of Q2 2026.
Ligand Pharmaceuticals was a new Jupiter Asset Management position in Q2 2026.
Ligand Pharmaceuticals made up ﹤0.01% of Jupiter Asset Management's portfolio in Q2 2026, its #508 holding.
Jupiter Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
Jupiter Asset Management's Ligand Pharmaceuticals position peaked at $2.93M in Q4 2020.
417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.